Dawn Shao Ting Lim
Overview
Explore the profile of Dawn Shao Ting Lim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoon S, Goh H, Lee P, Tan H, Teh M, Lim D, et al.
JMIR Hum Factors
. 2024 Jun;
11:e50939.
PMID: 38869934
Background: The clinical management of type 2 diabetes mellitus (T2DM) presents a significant challenge due to the constantly evolving clinical practice guidelines and growing array of drug classes available. Evidence...
2.
Fleseriu M, Lim D
Nat Rev Endocrinol
. 2023 May;
19(7):373-374.
PMID: 37202590
No abstract available.
3.
Tan S, Tan H, Zhu L, Loh L, Lim D, Swee D, et al.
Endocr Connect
. 2023 Feb;
12(4).
PMID: 36799247
Background: Adrenal insufficiency (AI) is potentially life-threatening, and accurate diagnosis is crucial. The first-line diagnostic test, the adrenocorticotrophic hormone (ACTH) stimulation test, measures serum total cortisol. However, this is affected...
4.
Fleseriu M, Langlois F, Lim D, Varlamov E, Melmed S
Lancet Diabetes Endocrinol
. 2022 Oct;
10(11):804-826.
PMID: 36209758
Growth hormone-secreting pituitary adenomas that cause acromegaly arise as monoclonal expansions of differentiated somatotroph cells and are usually sporadic. They are almost invariably benign, yet they can be locally invasive...
5.
Lim D, Fleseriu M
Endocr Pract
. 2022 Jan;
28(3):321-332.
PMID: 35032649
Acromegaly is associated with significant morbidity and mortality if it is not appropriately treated. In addition to insulin-like growth factor 1 and growth hormone normalization as well as tumor shrinkage,...
6.
Varlamov E, Wood M, Prola Netto J, Thiessen J, Kim J, Lim D, et al.
Pituitary
. 2020 Sep;
23(6):672-680.
PMID: 32870441
Purpose: To investigate demographic, imaging and laboratory characteristics, and treatment outcomes of acromegaly patients who have bihormonal (BA) growth hormone (GH) and prolactin (PRL) immunoreactive adenomas compared to patients who...
7.
Wagner J, Langlois F, Lim D, McCartney S, Fleseriu M
Front Endocrinol (Lausanne)
. 2019 Feb;
9:805.
PMID: 30745894
Hypercortisolism has been implicated in the development of venous thromboembolic events (VTE). We aimed to characterize VTE risk in endogenous Cushing's syndrome (CS) patients, compare that risk to other pathologies,...
8.
Langlois F, Manea A, Lim D, McCartney S, Yedinak C, Cetas J, et al.
Endocrine
. 2018 Oct;
63(3):463-469.
PMID: 30338480
Background: Rathke's cleft cysts (RCC) are lesions that arise from Rathke's pouch. Though frequently incidental, resulting symptoms in a minority of cases are indicators for surgical resection, which may prove...
9.
Loh W, Lim D, Loh L, Kek P
Endocrinol Metab (Seoul)
. 2018 Aug;
33(3):355-363.
PMID: 30112867
Background: The aim of this study was to investigate the factors associated with resolution of hypertension after adrenalectomy in patients with primary aldosteronism. A secondary aim was to describe our...
10.
Langlois F, Lim D, Varlamov E, Yedinak C, Cetas J, McCartney S, et al.
Endocrine
. 2017 Oct;
58(3):528-534.
PMID: 29043561
Purpose: Study and comparison of characteristics of silent growth hormone adenomas (SGHA), silent corticotroph adenomas (SCA), and silent gonadotroph adenomas (SGA) in a single institution cohort of surgically treated pituitary...